Table 1. Baseline characteristics of patients, tumor and surgery.
<40 y n = 1453 |
40−50 y n = 3420 |
51−65 y n = 3510 |
>65 y n = 566 |
all patients n = 8949 |
p value* | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|
n | Valid % | n | Valid % | n | Valid % | n | Valid % | n | Valid % | ||
Tumor stage | <0.001 | ||||||||||
cT1 | 135 | 9.4 | 283 | 8.3 | 192 | 5.5 | 24 | 4.3 | 634 | 7.1 | |
cT2 | 984 | 68.3 | 2189 | 64.5 | 2175 | 62.4 | 310 | 55.3 | 5658 | 63.7 | |
cT3 | 214 | 14.9 | 586 | 17.3 | 567 | 16.3 | 95 | 16.9 | 1462 | 16.5 | |
cT4a-c | 50 | 3.5 | 181 | 5.3 | 277 | 8.0 | 67 | 11.9 | 575 | 6.5 | |
cT4d | 57 | 4.0 | 153 | 4.5 | 272 | 7.8 | 65 | 11.6 | 547 | 6.2 | |
Missing | 73 | 0.8 | |||||||||
Nodal status | 0.031 | ||||||||||
N0 | 731 | 51.6 | 1670 | 49.7 | 1649 | 47.9 | 249 | 44.5 | 4299 | 49.0 | |
N 1−3 | 619 | 43.7 | 1518 | 45.2 | 1578 | 45.8 | 272 | 48.6 | 3987 | 45.4 | |
N 4−9 | 50 | 3.5 | 131 | 3.9 | 163 | 4.7 | 32 | 5.7 | 376 | 4.3 | |
N >10 | 18 | 1.3 | 38 | 1.1 | 56 | 1.6 | 7 | 1.3 | 119 | 1.4 | |
Missing | 168 | 1.9 | |||||||||
Histological type | <0.001 | ||||||||||
Ductal invasive | 1221 | 85.7 | 2721 | 81.5 | 2720 | 79.0 | 439 | 77.6 | 7101 | 81.0 | |
Lobular invasive | 86 | 6.0 | 400 | 12.0 | 502 | 14.6 | 78 | 13.8 | 1066 | 12.2 | |
Others | 117 | 8.2 | 217 | 6.5 | 221 | 6.4 | 49 | 8.7 | 604 | 6.9 | |
Missing | 178 | 2.0 | |||||||||
Tumor grade | <0.001 | ||||||||||
G1 | 42 | 3.1 | 137 | 4.2 | 119 | 3.6 | 17 | 3.1 | 315 | 3.7 | |
G2 | 684 | 49.8 | 1812 | 55.6 | 1839 | 55.6 | 322 | 59.1 | 4657 | 54.9 | |
G3 | 647 | 47.1 | 1312 | 40.2 | 1350 | 40.8 | 206 | 37.8 | 3515 | 41.4 | |
Missing | 462 | 5.2 | |||||||||
ER status | <0.001 | ||||||||||
Negative | 630 | 45.4 | 1244 | 37.8 | 1206 | 35.8 | 198 | 35.2 | 3278 | 38.1 | |
Positive | 758 | 54.6 | 2050 | 62.2 | 2160 | 64.2 | 365 | 64.8 | 5333 | 61.9 | |
Missing | 338 | 3.8 | |||||||||
PR status | <0.001 | ||||||||||
Negative | 700 | 50.5 | 1415 | 43.0 | 1611 | 48.0 | 284 | 50.5 | 4010 | 46.6 | |
Positive | 687 | 49.5 | 1878 | 57.0 | 1746 | 52.0 | 278 | 49.5 | 4589 | 53.4 | |
Missing | 350 | 3.9 | |||||||||
HER-2 Status | 0.072 | ||||||||||
Negative | 829 | 72.1 | 2050 | 74.4 | 1974 | 74.2 | 371 | 78.4 | 5224 | 74.2 | |
Positive | 320 | 27.9 | 707 | 25.6 | 688 | 25.8 | 102 | 21.6 | 1817 | 25.8 | |
Missing | 1908 | 21.3 | |||||||||
Molecular subtypes | <0.001 | ||||||||||
HR positive/HER2− | 463 | 42.3 | 1309 | 49.2 | 1319 | 51.8 | 256 | 54.9 | 3347 | 49.5 | |
HR positive/HER2+ | 174 | 15.9 | 419 | 15.8 | 358 | 14.1 | 54 | 11.6 | 1005 | 14.9 | |
HR negative/HER2+ | 137 | 12.5 | 275 | 10.3 | 313 | 12.3 | 48 | 10.3 | 773 | 11.4 | |
TNBC | 320 | 29.3 | 655 | 24.6 | 555 | 21.8 | 108 | 23.2 | 1638 | 24.2 | |
Missing | 2186 | 24.4 | |||||||||
BMI | <0.001 | ||||||||||
<18.5 | 42 | 2.9 | 63 | 1.9 | 30 | 0.9 | 3 | 0.5 | 138 | 1.6 | |
18.5−24.9 | 895 | 62.0 | 1802 | 53.1 | 1377 | 39.7 | 189 | 33.4 | 4263 | 48.0 | |
25.0−29.9 | 325 | 22.5 | 1009 | 29.7 | 1224 | 35.3 | 215 | 38.0 | 2773 | 31.2 | |
30.0−39.9 | 163 | 11.3 | 480 | 14.1 | 784 | 22.6 | 145 | 25.6 | 1572 | 17.7 | |
≥40 | 19 | 1.3 | 40 | 1.2 | 55 | 1.6 | 14 | 2.5 | 128 | 1.4 | |
Missing | 75 | 0.8 | |||||||||
Surgery Type | <0.001 | ||||||||||
Breast conserving therapy | 992 | 71.9 | 2321 | 70.7 | 2333 | 70.1 | 310 | 58.5 | 5956 | 69.9 | |
Mastectomy | 387 | 28.1 | 964 | 29.3 | 997 | 29.9 | 220 | 41.5 | 2568 | 30.1 | |
Missing | 425 | 4.7 |
* χ2 or Fisher´s test.